跳至主要内容
临床试验/NCT05565326
NCT05565326招募中不适用

Pilot Study on Response Assessment During MR-guided Radiation Therapy for Glioblastoma Multiforme

University of Zurich1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
To assess target volume changes with MRI during fractionated MR-guided radiation therapy.

研究概览

简要总结

The study seeks to assess the response of glioblastoma multiforme to treatment using weekly low field (0.35 T) MR-images of the brain at a MRIdian® linac system during standard radiotherapy at the same system. A total of 20 patients in a single arm will be recruited for this investigation.

The imaging data will be used to evaluate the change in tumor volume over the course of the treatment and to perform radiomics in order to investigate the possibility of response prediction using these images.

In order to assure sufficient image quality, prior to the main investigation, a group of up to 20 volunteers has MR scans taken with identical sequences to the main study phase.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

To assess target volume changes with MRI during fractionated MR-guided radiation therapy.

时间窗: 6 Months

次要结局

  • Value of target changes with MRI during fractionated MR-guided radiation therapy(6 Months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Mayinger

MD

University of Zurich

研究点 (1)

Loading locations...

相似试验